{"id":46001,"date":"2022-07-11T08:01:41","date_gmt":"2022-07-11T06:01:41","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/ka-imagings-reveal-35c-images-shown-to-increase-lung-lesion-visibility\/"},"modified":"2022-07-11T08:01:41","modified_gmt":"2022-07-11T06:01:41","slug":"ka-imagings-reveal-35c-images-shown-to-increase-lung-lesion-visibility","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/ka-imagings-reveal-35c-images-shown-to-increase-lung-lesion-visibility\/","title":{"rendered":"KA Imaging\u2019s Reveal 35C Images Shown to Increase Lung Lesion Visibility"},"content":{"rendered":"
\n

\nInitial Results from Clinical Trial on Lung Lesion Detection Will be Presented at ECR 2022<\/i>\n<\/p>\n

WATERLOO, Ontario–(BUSINESS WIRE)–#ECR2020<\/a>–KA Imaging, a company that develops innovative X-ray imaging solutions, announced the initial results from a study examining the diagnostic value of single-exposure dual-energy subtraction radiography in lung lesion detection<\/i>.\n<\/p>\n

<\/a><\/p>\n

\nIn the study, a radiologist blinded to standard-of-care CT results was first asked to identify anomalies in the conventional X-ray. The same task was given right after that, with supplemented single-exposure dual-energy images. Quoting directly from the poster, \u201clesion visibility reportedly increased in 45% of the cases when supplemental dual-energy images were included1<\/sup>.\u201d Findings were validated using CT.\n<\/p>\n

\n\u201cLung cancer is the leading cause of cancer death; unfortunately, statistics show that it is rarely detected early,\u201d explains Karim S. Karim, CTO of KA Imaging. \u201cThe promising results from this trial show that spectral images can play an important role in earlier detection for better outcomes,\u201d says Amol Karnick, President and CEO.\n<\/p>\n

\nThe study will be presented in an e-poster at this year\u2019s European Congress of Radiology (ECR). In addition to the e-poster at the scientific congress, KA Imaging is part of the technical exhibition at Expo X4, booth 406.\n<\/p>\n

\nECR is one of the largest medical meetings in Europe and the second-largest radiological meeting in the world. ECR attendees span all areas of the radiology arena including radiology professionals, radiographers, physicists, industry representatives, and press reporters for both the medical and consumer press.\n<\/p>\n

\nRecently, KA Imaging announced that its patented single-exposure dual-energy technology is now branded Spectral<\/i>DR<\/b>\u2122. The Spectral<\/i>DR<\/b>\u2122 technology enables dual-energy subtraction, providing bone and tissue differentiation with a single standard X-ray exposure. <\/b>It acquires three images simultaneously (DR, bone and soft tissue dual-energy X-ray images). The technology mimics the workflow, dose and techniques of state-of-the-art mobile DR X-ray detectors.\n<\/p>\n

\nAbout KA Imaging<\/b>\n<\/p>\n

\nA spin-off from the University of Waterloo, KA Imaging specializes in developing innovative X-ray imaging technologies and systems, providing solutions to the medical, veterinary, and non-destructive test industrial markets. For more information, please visit www.kaimaging.com<\/a>.\n<\/p>\n

\n1. S. L. Maurino, K. S. Karim, V. Venkatesh. Diagnostic value of single\u2010exposure dual\u2010energy subtraction radiography in lung lesion detection: initial results. European Congress of Radiology-ECR 2022, 2022.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nFernanda Fraga
\n
Media Relations
\n
ffraga@kaimaging.com<\/a>
T: 226.215.9897\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Initial Results from Clinical Trial on Lung Lesion Detection Will be Presented at ECR 2022 WATERLOO, Ontario–(BUSINESS WIRE)–#ECR2020–KA Imaging, a company that develops innovative X-ray imaging solutions, announced the initial results from a study examining the diagnostic value of single-exposure dual-energy subtraction radiography in lung lesion detection. In the study, a radiologist blinded to standard-of-care … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":["entry","post","publish","author-business","post-46001","format-standard","category-industry"],"yoast_head":"\nKA Imaging\u2019s Reveal 35C Images Shown to Increase Lung Lesion Visibility - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/ka-imagings-reveal-35c-images-shown-to-increase-lung-lesion-visibility\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"KA Imaging\u2019s Reveal 35C Images Shown to Increase Lung Lesion Visibility - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Initial Results from Clinical Trial on Lung Lesion Detection Will be Presented at ECR 2022 WATERLOO, Ontario–(BUSINESS WIRE)–#ECR2020–KA Imaging, a company that develops innovative X-ray imaging solutions, announced the initial results from a study examining the diagnostic value of single-exposure dual-energy subtraction radiography in lung lesion detection. In the study, a radiologist blinded to standard-of-care ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/ka-imagings-reveal-35c-images-shown-to-increase-lung-lesion-visibility\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-07-11T06:01:41+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220710005001\/en\/1504710\/21\/Standard-Color.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ka-imagings-reveal-35c-images-shown-to-increase-lung-lesion-visibility\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ka-imagings-reveal-35c-images-shown-to-increase-lung-lesion-visibility\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"KA Imaging\u2019s Reveal 35C Images Shown to Increase Lung Lesion Visibility\",\"datePublished\":\"2022-07-11T06:01:41+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ka-imagings-reveal-35c-images-shown-to-increase-lung-lesion-visibility\\\/\"},\"wordCount\":390,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ka-imagings-reveal-35c-images-shown-to-increase-lung-lesion-visibility\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220710005001\\\/en\\\/1504710\\\/21\\\/Standard-Color.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ka-imagings-reveal-35c-images-shown-to-increase-lung-lesion-visibility\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ka-imagings-reveal-35c-images-shown-to-increase-lung-lesion-visibility\\\/\",\"name\":\"KA Imaging\u2019s Reveal 35C Images Shown to Increase Lung Lesion Visibility - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ka-imagings-reveal-35c-images-shown-to-increase-lung-lesion-visibility\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ka-imagings-reveal-35c-images-shown-to-increase-lung-lesion-visibility\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220710005001\\\/en\\\/1504710\\\/21\\\/Standard-Color.jpg\",\"datePublished\":\"2022-07-11T06:01:41+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ka-imagings-reveal-35c-images-shown-to-increase-lung-lesion-visibility\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ka-imagings-reveal-35c-images-shown-to-increase-lung-lesion-visibility\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ka-imagings-reveal-35c-images-shown-to-increase-lung-lesion-visibility\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220710005001\\\/en\\\/1504710\\\/21\\\/Standard-Color.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220710005001\\\/en\\\/1504710\\\/21\\\/Standard-Color.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ka-imagings-reveal-35c-images-shown-to-increase-lung-lesion-visibility\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"KA Imaging\u2019s Reveal 35C Images Shown to Increase Lung Lesion Visibility\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"KA Imaging\u2019s Reveal 35C Images Shown to Increase Lung Lesion Visibility - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/ka-imagings-reveal-35c-images-shown-to-increase-lung-lesion-visibility\/","og_locale":"en_US","og_type":"article","og_title":"KA Imaging\u2019s Reveal 35C Images Shown to Increase Lung Lesion Visibility - Pharma Trend","og_description":"Initial Results from Clinical Trial on Lung Lesion Detection Will be Presented at ECR 2022 WATERLOO, Ontario–(BUSINESS WIRE)–#ECR2020–KA Imaging, a company that develops innovative X-ray imaging solutions, announced the initial results from a study examining the diagnostic value of single-exposure dual-energy subtraction radiography in lung lesion detection. In the study, a radiologist blinded to standard-of-care ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/ka-imagings-reveal-35c-images-shown-to-increase-lung-lesion-visibility\/","og_site_name":"Pharma Trend","article_published_time":"2022-07-11T06:01:41+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220710005001\/en\/1504710\/21\/Standard-Color.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/ka-imagings-reveal-35c-images-shown-to-increase-lung-lesion-visibility\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/ka-imagings-reveal-35c-images-shown-to-increase-lung-lesion-visibility\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"KA Imaging\u2019s Reveal 35C Images Shown to Increase Lung Lesion Visibility","datePublished":"2022-07-11T06:01:41+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/ka-imagings-reveal-35c-images-shown-to-increase-lung-lesion-visibility\/"},"wordCount":390,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/ka-imagings-reveal-35c-images-shown-to-increase-lung-lesion-visibility\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220710005001\/en\/1504710\/21\/Standard-Color.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/ka-imagings-reveal-35c-images-shown-to-increase-lung-lesion-visibility\/","url":"https:\/\/pharma-trend.com\/en\/ka-imagings-reveal-35c-images-shown-to-increase-lung-lesion-visibility\/","name":"KA Imaging\u2019s Reveal 35C Images Shown to Increase Lung Lesion Visibility - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/ka-imagings-reveal-35c-images-shown-to-increase-lung-lesion-visibility\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/ka-imagings-reveal-35c-images-shown-to-increase-lung-lesion-visibility\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220710005001\/en\/1504710\/21\/Standard-Color.jpg","datePublished":"2022-07-11T06:01:41+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/ka-imagings-reveal-35c-images-shown-to-increase-lung-lesion-visibility\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/ka-imagings-reveal-35c-images-shown-to-increase-lung-lesion-visibility\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/ka-imagings-reveal-35c-images-shown-to-increase-lung-lesion-visibility\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220710005001\/en\/1504710\/21\/Standard-Color.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220710005001\/en\/1504710\/21\/Standard-Color.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/ka-imagings-reveal-35c-images-shown-to-increase-lung-lesion-visibility\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"KA Imaging\u2019s Reveal 35C Images Shown to Increase Lung Lesion Visibility"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/46001","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=46001"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/46001\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=46001"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=46001"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=46001"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}